Skip to main content
Clinical Trials/KCT0001451
KCT0001451Recruiting未知

Blind intra-articular injection with low- and high-dose corticosteroid in adhesive capsulitis: a randomized, double-blind, controlled trial

Ajou University Hospital0 sites94 target enrollmentStarted: TBDLast updated:
Conditions

Trial Snapshot

Phase
未知
Status
Recruiting
Sponsor
Enrollment
94

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional Study

Eligibility Criteria

Ages
20(Year) to 70(Year) (—)
Sex
All

Inclusion Criteria

  • (1) Age, 20 to 70 years old
  • (2) stage 2 (freezing stage) of adhesive capsulitis at least 1 month of pain duration: pain and stiffness in predominantly one shoulder for =1 months
  • (3) average pain intensity during a day defined as a score of 5 points or more on a 10-cm visual analog scale (VAS) rated from 0 (no pain) to 10 (worst imaginable pain)

Exclusion Criteria

  • (1) Secondary adhesive capsulitis (suspicious of secondary to other causes including inflammatory, metabolic, or infectious arthritis; cerebrovascular accident; tumor; or fracture)
  • (2) Definite rotator cuff lesion; complete or full-thickness tear of the rotator cuff
  • (3) Previous corticosteroid injection at the affected shoulder within 1 month
  • (4) High-risk bleeding tendency; taking medication such as an anticoagulant with the exception of those who agreed to stop for a minimum of 5 days before the injection.
  • (5) Uncontrolled serum glucose level in diabetes patient (>180mg/dl)
  • (6) Previous history of shoulder surgery

Investigators

Sponsor
Ajou University Hospital

Similar Trials